Pilot randomised controlled trial of community pharmacy administration of buprenorphine versus methadone

International Journal of Pharmacy Practice

Volumn 14, Issue 4, 2006, Pages 243-248

  Cameron, Isobel M ^a   Matheson, Catriona I ^a   Bond, Christine M ^a   McNamee, Paul ^a   Lawrie, Thane ^a   Robinson, Andrew ^b   Robertson, George ^b   Eagles, Lucy E ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROYAL CORNHILL HOSPITAL   (United Kingdom)

^c NHS GRAMPIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PHARMACY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE TITRATION; DRUG MISUSE; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERVIEW; MAINTENANCE THERAPY; MALE; MEDICAL PRACTICE; OPIATE ADDICTION; PHARMACIST; PHARMACIST ATTITUDE; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; WITHDRAWAL SYNDROME;

EID: 33845937949     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.14.4.0003     Document Type: Article

References (24)

1. Department of Health. Drug misuse and dependence - guidelines on clinical management. London: The Stationery Office; 1999.
2. Simoens S, Matheson CI, Bond CM, Ludbrook A. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence: a review of the evidence. Br J Gen Pract 2005;55:139-46.
3. Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 1994;55:569-80.
4. Ling W, Wesson DR, Charuvastra C, Klett CJ. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry 1996;53:401-7.
5. Johnson RE, Eissenberg T, Stitzer ML et al. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend 1995;40:17-25.
6. Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992;267: 2750-5.
7. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am J Psychiatry 1994;151:1025-30.
8. Eder H, Fischer G, Gombas W et al. Comparison of buprenorphine and methadone maintenance in opiate addicts. Eur Addict Res 1998;4(suppl 1):3-7.
9. Uehlinger C, Deglon JJ, Livoti S et al. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Eur Addict Res 1998;4:13-18.
10. Pani PP, Maremmani I, Pirastu R, Tagliamonte A, Gessa GL. Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. Drug Alcohol Depend 2000;60:39-50.
11. Johnson RE, Fudala PJ, Jaffe JH. Outpatient comparison of buprenorphine and methadone maintenance. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology. NIDA Res Monog 1991;105:585-6.
12. Petitjean S, Stohler R, Deglon JJ et al. Double-blind randomised trial of buprenorphine and methadone in opiate dependence. Drug Alcohol Depend 2001;62:97-104.
13. Mattick RP, Ali R, White JM, O'Brien S, Wolk S, Danz C. Buprenorphine versus methadone maintenance therarpy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003;98:441-52.
14. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Cochrane review). The Cochrane Library Issue 3. Oxford: Update Software; 2004.
15. Department of Health. Prescription cost analysis data for England (1999-2003). London: Crown Copyright SD1E; 2005. www.publications.doh.gov.uk/ prescriptionstatistics/(accessed August 9, 2006).
16. Scottish Health Statistics. Prescription Cost Analysis for Scotland (2001-2003), 2005. www.isdscotland.org/isd (accessed August 9, 2006).
17. Hammersley R, Lavelle T, Forsyth A. Buprenorphine and temazepam - abuse. Br J Addict 1990;85:301-3.
18. Sakol MS, Stark C, Sykes R. Buprenorphine and temazepam abuse by drug takers in Glasgow - an increase. Br J Addict 1989;84:439-41.
19. Euroquol Group. Euroquol - a new facility for the measurement of health-related quality of life. Health Pol 1990;16:199-208.
20. Grafham E, Matheson C, Bond CM. Specialist drug misuse nurse's motivation, clinical decision making and professional communication: an exploratory study. J Psychiatr Ment Health Nurs 2004;11:690-7.
21. Gates S, Brocklehurst P, Campbell M, Elbourne D. Recruitment to multicentre trials. Int J Obstet Gynaecol 2004;111:3-5.
22. Ford C, Morton S, Linzeris N, Bury J, Gerada C. Guidance for the use of buprenorphine for the treatment of opioid dependence in primary care, 2nd edn. London: Royal College of General Practitioners; 2004.
23. British National Formulary (47). London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2004.
24. Ford C, Barnard J, Bury J et al. Guidance on the use of methadone for the treatment of opioid dependence in primary care. London: Royal College of General Practitioners; 2005.